Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. [PDF]
Patients with human immunodeficiency virus (HIV) infection have a high risk of developing virally-mediated cancers. These tumors have several features that could make them vulnerable to immune checkpoint inhibitors (ICIs) including, but not limited to ...
Adashek, Jacob J +3 more
core
Purpose of review: Long-term survival of liver transplant recipients is threatened by increased rates of de-novo malignancy and recurrence of hepatocellular carcinoma (HCC), both events tightly related to immunosuppression.
Burroughs, AK +2 more
core
Rhinoscleroma and nasal non-Hodgkin lymphoma
Introduction: Rhinoscleroma, a rare nasal granulomatous disease, is caused by Klebsiella rhinoscleromatis. The nose is the primary occurrence region. Nasal non-Hodgkin lymphoma is a rare cancer, and could be of T or B type.
Oliveira, Henrique Fernandes de +4 more
doaj
Clinical and Biomarker Characteristic of Lymphoma Patients in Hasan Sadikin Lymphoma Registry
Amaylia Oehadian,1 Andini Kartikasari,2 Lusi Mersiana,1 Stephanie Victoria Gunadi,3 Gusti Fungani,1 Putri Vidyaniati,1 Dimmy Prasetya,1 Indra Wijaya,1 Pandji Irani Fianza,1 Trinugroho Heri Fadjari,1 Nanny Natalia Sutedjo4 1Division of Hematology and ...
Oehadian A +10 more
doaj
Intraosseous Non-Hodgkin Lymphoma Mimicking a Periapical Lesion. [PDF]
Cunha LTMQ +6 more
europepmc +1 more source
Secondary primary malignancies in indolent non-Hodgkin lymphoma patients receiving frontline bendamustine-rituximab. [PDF]
Davies GA +7 more
europepmc +1 more source
Primary extranodal marginal zone non-hodgkin lymphoma of the prostate: a case report. [PDF]
Gao X, Wang X, Wang X, Cai H.
europepmc +1 more source
Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma. [PDF]
Figueiredo F +4 more
europepmc +1 more source
A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree. [PDF]
Jain NP +4 more
europepmc +1 more source
Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in patients with non-Hodgkin's lymphoma in the United Kingdom (UK) [PDF]
Introduction: We report a cost-effectiveness evaluation of granulocyte colony-stimulating factors (G-CSFs) for prevention of febrile neutropenia (FN) following chemotherapy for non-Hodgkin’s lymphoma (NHL) in the United Kingdom (UK).
Akehurst, R. +3 more
core

